Product Images Perindopril Erbumine

The image shows a graph of time-to-event analysis comparing the efficacy of a placebo versus a medication called Perindopril in preventing cardiovascular mortality, nonfatal myocardial infarction or cardiac arrest. The primary endpoint favors the use of Perindopril with a statistically significant difference (Logrank p=0.0003). The x-axis represents the time in years, and the y-axis represents the proportion of patients who had an event. The number of patients at risk is also included at different time points.*

The text describes a figure showing the beneficial effect of Perindopril treatment on the primary endpoint in different subgroups such as male and female patients, age groups, patients with or without previous medical history, and those taking medication for hypertension, diabetes or lipid-lowering. The figure also shows the percentage of primary events and the number of patients in each group, represented by the size of the squares. The results suggest that Perindopril treatment is more effective than a placebo in reducing the primary endpoint.*

This is a description of Perindopril Erbumine tablets. Each tablet contains 4mg of perindopril erbumine. The dosage and administration information should be found on accompanying literature. The tablets should be stored at a controlled room temperature of 20 to 25°C and protected from moisture. They are manufactured by Patheon Pharmaceuticals, Inc. and marketed by Lannett. These tablets are a product of France and are sold in a bottle containing 100 tablets. Finally, it is advised to keep the tablets out of reach of children.*

Perindopril Erbumine Tablets, each containing 8 mg, are manufactured by Patheon Pharmaceuticals, Inc. and marketed by Lannett Company, Inc. These tablets must be stored at a controlled room temperature between 20°C to 25°C and protected from moisture. The recommended dosage and administration instructions are provided in accompanying literature. The product is made in France and comes in a bottle of 100 tablets with the NDC number 0527-1920-01. It is available on prescription only and should be kept out of reach of children.*